AP9200379A0 - Pyrrolidinones - Google Patents

Pyrrolidinones

Info

Publication number
AP9200379A0
AP9200379A0 AP92/00379A AP9200379A AP9200379A0 AP 9200379 A0 AP9200379 A0 AP 9200379A0 AP 92/00379 A AP92/00379 A AP 92/00379A AP 9200379 A AP9200379 A AP 9200379A AP 9200379 A0 AP9200379 A0 AP 9200379A0
Authority
AP
ARIPO
Prior art keywords
pyrrolidinones
Prior art date
Application number
AP92/00379A
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US69462491A priority Critical
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of AP9200379A0 publication Critical patent/AP9200379A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
AP92/00379A 1991-05-02 1992-04-30 Pyrrolidinones AP9200379A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US69462491A true 1991-05-02 1991-05-02

Publications (1)

Publication Number Publication Date
AP9200379A0 true AP9200379A0 (en) 1992-04-30

Family

ID=24789624

Family Applications (1)

Application Number Title Priority Date Filing Date
AP92/00379A AP9200379A0 (en) 1991-05-02 1992-04-30 Pyrrolidinones

Country Status (11)

Country Link
EP (1) EP0584208A4 (en)
JP (1) JPH06507405A (en)
CN (1) CN1067244A (en)
AP (1) AP9200379A0 (en)
AU (1) AU1917092A (en)
CA (1) CA2102106A1 (en)
IE (1) IE921376A1 (en)
MX (1) MX9202090A (en)
PT (1) PT100441A (en)
WO (1) WO1992019594A1 (en)
ZA (1) ZA9203210B (en)

Families Citing this family (125)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5698711A (en) 1991-01-28 1997-12-16 Rhone-Poulenc Rorer Limited Compounds containing phenyl linked to aryl or heteroaryl by an aliphatic- or heteroatom-containing linking group
US5679696A (en) * 1992-07-28 1997-10-21 Rhone-Poulenc Rorer Limited Compounds containing phenyl linked to aryl or heteroaryl by an aliphatic-or heteroatom-containing linking group
GB9212673D0 (en) * 1992-06-15 1992-07-29 Celltech Ltd Chemical compounds
GB9222253D0 (en) * 1992-10-23 1992-12-09 Celltech Ltd Chemical compounds
AT234270T (en) * 1992-12-02 2003-03-15 Pfizer Cathecoldiether as selective PDE IV inhibition medium
US5814651A (en) * 1992-12-02 1998-09-29 Pfizer Inc. Catechol diethers as selective PDEIV inhibitors
GB9226830D0 (en) * 1992-12-23 1993-02-17 Celltech Ltd Chemical compounds
TW263495B (en) * 1992-12-23 1995-11-21 Celltech Ltd
US5622977A (en) * 1992-12-23 1997-04-22 Celltech Therapeutics Limited Tri-substituted (aryl or heteroaryl) derivatives and pharmaceutical compositions containing the same
GB9304920D0 (en) * 1993-03-10 1993-04-28 Celltech Ltd Chemical compounds
GB9304919D0 (en) * 1993-03-10 1993-04-28 Celltech Ltd Chemical compounds
GB9311281D0 (en) * 1993-06-01 1993-07-21 Rhone Poulenc Rorer Ltd Novel composition of matter
US5998428A (en) * 1995-05-31 1999-12-07 Smithkline Beecham Corporation Compounds and methods for treating PDE IV-related diseases
PT710109E (en) * 1993-06-18 2005-01-31 Smithkline Beecham Corp Method for identifying a pde iv inhibitor
CA2160928C (en) 1993-07-28 2005-07-05 Garry Fenton Compounds as pde iv and tnf inhibitors
US5665754A (en) * 1993-09-20 1997-09-09 Glaxo Wellcome Inc. Substituted pyrrolidines
PT730587E (en) * 1993-11-26 2000-05-31 Pfizer 3-aril-2-isoxazolines as anti-inflammatory agents
CZ283564B6 (en) * 1993-11-26 1998-05-13 Pfizer Inc. 3-aryl-2-isoxazoline-5-hydroxamic acids and pharmaceutical compositions based thereon
EP0738268B1 (en) * 1993-12-22 2004-03-03 Celltech R&D Limited Trisubstituted phenyl derivatives, processes for their preparation and their use as phosphodiesterase (type iv) inhibitors
GB9326173D0 (en) * 1993-12-22 1994-02-23 Celltech Ltd Chemical compounds and process
CA2143143A1 (en) * 1994-03-08 1995-09-09 Toshihiko Tanaka 3-phenylpyrrolidine derivatives
CA2184914C (en) * 1994-03-09 2000-09-19 Victoria L. Cohan Isoxazoline compounds as 5-lipoxygenase inhibitors
ES2118557T3 (en) * 1994-03-09 1998-09-16 Pfizer Isoxazoline compounds as inhibitors of TNF release.
EP0758233B1 (en) * 1994-04-21 2003-12-03 Schering Aktiengesellschaft Pde iv inhibitors for treating multiple sclerosis
US5672622A (en) * 1994-04-21 1997-09-30 Berlex Laboratories, Inc. Treatment of multiple sclerosis
EP1380291A1 (en) * 1994-04-21 2004-01-14 Schering Aktiengesellschaft PDE IV inhibitors for treating multiple sclerosis
US6060501A (en) * 1994-06-02 2000-05-09 Schering Aktiengesellschaft Combined treatment of multiple sclerosis
US5786354A (en) * 1994-06-21 1998-07-28 Celltech Therapeutics, Limited Tri-substituted phenyl derivatives and processes for their preparation
US6245774B1 (en) 1994-06-21 2001-06-12 Celltech Therapeutics Limited Tri-substituted phenyl or pyridine derivatives
GB9412573D0 (en) * 1994-06-22 1994-08-10 Celltech Ltd Chemical compounds
GB9412571D0 (en) 1994-06-22 1994-08-10 Celltech Ltd Chemical compounds
GB9412672D0 (en) * 1994-06-23 1994-08-10 Celltech Ltd Chemical compounds
US5591776A (en) * 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
US5563143A (en) * 1994-09-21 1996-10-08 Pfizer Inc. Catechol diether compounds as inhibitors of TNF release
US5665737B1 (en) * 1994-10-12 1999-02-16 Euro Celtique Sa Substituted benzoxazoles
JPH10508032A (en) * 1994-12-13 1998-08-04 ユーロ−セルティーク,エス.エイ. Arylthio xanthines
AU706159B2 (en) * 1995-02-10 1999-06-10 Schering Aktiengesellschaft Pharmaceutical preparations for TNF inhibition
US6268373B1 (en) 1995-06-07 2001-07-31 Euro-Celtique S.A. Trisubstituted thioxanthines
US5658940A (en) * 1995-10-06 1997-08-19 Celgene Corporation Succinimide and maleimide cytokine inhibitors
DE19540475A1 (en) * 1995-10-20 1997-04-24 Schering Ag chiral methylphenyloxazolidinones
GB9523675D0 (en) 1995-11-20 1996-01-24 Celltech Therapeutics Ltd Chemical compounds
GB9526246D0 (en) * 1995-12-21 1996-02-21 Celltech Therapeutics Ltd Chemical compounds
GB9526245D0 (en) * 1995-12-21 1996-02-21 Celltech Therapeutics Ltd Chemical compounds
GB9608435D0 (en) * 1996-04-24 1996-06-26 Celltech Therapeutics Ltd Chemical compounds
ES2201299T3 (en) * 1996-06-25 2004-03-16 Pfizer Inc. Substituted indazole derivatives and their use as inhibitors of phosphodiesterase (PDE) type IV and tumor necrosis factor (TNF) `.
GB9619284D0 (en) * 1996-09-16 1996-10-30 Celltech Therapeutics Ltd Chemical compounds
US5744473A (en) * 1996-09-16 1998-04-28 Euro-Celtique, S.A. PDE IV inhibitors: "bis-compounds"
GB9622363D0 (en) 1996-10-28 1997-01-08 Celltech Therapeutics Ltd Chemical compounds
GB9625184D0 (en) * 1996-12-04 1997-01-22 Celltech Therapeutics Ltd Chemical compounds
JP2001507349A (en) 1996-12-23 2001-06-05 セルテック セラピューティックス リミテッド Fused polycyclic 2-aminopyrimidine derivatives, their use as their production and protein tyrosine kinase inhibitor
GB9705361D0 (en) 1997-03-14 1997-04-30 Celltech Therapeutics Ltd Chemical compounds
KR19980074060A (en) * 1997-03-21 1998-11-05 김윤배 Novel substituted 3,4-dialkoxyphenyl derivatives
GB9713087D0 (en) * 1997-06-20 1997-08-27 Celltech Therapeutics Ltd Chemical compounds
GB9914258D0 (en) 1999-06-18 1999-08-18 Celltech Therapeutics Ltd Chemical compounds
GB9924862D0 (en) 1999-10-20 1999-12-22 Celltech Therapeutics Ltd Chemical compounds
US6680336B2 (en) 1999-12-15 2004-01-20 Icos Corporation Cyclic AMP-specific phosphodiesterase inhibitors
US6376489B1 (en) * 1999-12-23 2002-04-23 Icos Corporation Cyclic AMP-specific phosphodiesterase inhibitors
US6372777B1 (en) * 1999-12-23 2002-04-16 Icos Corporation Cyclic AMP-specific phosphodiesterase inhibitors
US6348602B1 (en) 1999-12-23 2002-02-19 Icos Corporation Cyclic AMP-specific phosphodiesterase inhibitors
FR2803593B1 (en) * 2000-01-06 2002-02-15 Sanofi Synthelabo News tetrahydropyridine, process for their preparation and pharmaceutical compositions containing them
KR100755103B1 (en) * 2000-01-06 2007-09-04 사노피-아벤티스 Novel Tetrahydropyridines, Preparation Method and Pharmaceutical Compositions Containing Same
AU4215801A (en) 2000-03-16 2001-09-24 Inflazyme Pharm Ltd Benzylated pde4 inhibitors
IT1317049B1 (en) * 2000-06-23 2003-05-26 Sigma Tau Ind Farmaceuti Compounds useful for the preparation of medicaments having phosphodiesterase attivita'inibitrice iv.
WO2002081446A1 (en) * 2001-04-06 2002-10-17 Daewoong Co., Ltd. 3-cyclopentyloxy-4-methoxyphenyl-isoindolinone derivatives and the use thereof
WO2002081447A1 (en) * 2001-04-06 2002-10-17 Daewoong Pharmaceutical Co., Ltd. 3-cyclopentyloxy-4-methoxyphenyl-isothiazolinone derivatives and the use thereof
FR2823748B1 (en) * 2001-04-20 2004-02-20 Sanofi Synthelabo Tetrahydropyridyl-alkyl benzodiazines, process for their preparation and pharmaceutical compositions containing them
MXPA03010810A (en) 2001-05-29 2004-03-22 Schering Ag Cdk inhibiting pyrimidines, production thereof and their use as medicaments.
RU2340600C2 (en) * 2001-10-16 2008-12-10 Мемори Фармасьютиклз Корпорейшн Derivatives of 4-(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidone as pde-4 inhibitors for treatment of neurological syndromes
AU2003252259A1 (en) * 2002-07-26 2004-02-16 Nihon Nohyaku Co., Ltd. Novel haloalkylsulfonanilide derivatives, herbicides and usage thereof
JP2004107323A (en) * 2002-07-26 2004-04-08 Nippon Nohyaku Co Ltd New haloalkylsulfone anilide derivative, herbicide and use thereof
AU2003276596B8 (en) 2002-11-26 2009-03-05 Pfizer Products Inc. Piperidine compounds useful as PPAR activators
WO2004094375A2 (en) * 2003-04-16 2004-11-04 Memory Pharmaceuticals Corporation 4 - (3,4 - disubstituted phenyl) - pyrrolidin-2-one compounds as phosphodiesterase 4 inhibitors
WO2004094411A1 (en) 2003-04-18 2004-11-04 Memory Pharmaceuticals Corporation Pyrazole derivatives as phosphodiesterase 4 inhibitors
GB0401334D0 (en) 2004-01-21 2004-02-25 Novartis Ag Organic compounds
US20080085858A1 (en) * 2004-10-13 2008-04-10 Kyowa Hakko Kogyo Co., Ltd. Pharmaceutical Composition
WO2006041121A1 (en) * 2004-10-13 2006-04-20 Kyowa Hakko Kogyo Co., Ltd. Remedies/preventives for chronic skin disease
US7432266B2 (en) 2004-10-15 2008-10-07 Memory Pharmaceuticals Corporation Phosphodiesterase 4 inhibitors
EP1802615A1 (en) 2004-10-20 2007-07-04 Memory Pharmaceuticals Corporation Phosphodiesterase 4 inhibitors
GT200500281A (en) 2004-10-22 2006-04-24 Novartis Ag organic compounds.
GB0424284D0 (en) 2004-11-02 2004-12-01 Novartis Ag Organic compounds
GB0426164D0 (en) 2004-11-29 2004-12-29 Novartis Ag Organic compounds
US7517870B2 (en) 2004-12-03 2009-04-14 Fondazione Telethon Use of compounds that interfere with the hedgehog signaling pathway for the manufacture of a medicament for preventing, inhibiting, and/or reversing ocular diseases related with ocular neovascularization
GB0507577D0 (en) 2005-04-14 2005-05-18 Novartis Ag Organic compounds
GB0510390D0 (en) 2005-05-20 2005-06-29 Novartis Ag Organic compounds
US7910708B2 (en) 2005-10-21 2011-03-22 Novartis Ag Anti-IL13 human antibodies
GB0526244D0 (en) 2005-12-22 2006-02-01 Novartis Ag Organic compounds
GB0601951D0 (en) 2006-01-31 2006-03-15 Novartis Ag Organic compounds
RU2457209C2 (en) 2006-04-21 2012-07-27 Новартис Аг Purine derivatives applicable as adenosine receptor a2a agonists
CA2664378A1 (en) 2006-09-29 2008-04-03 Novartis Ag Pyrazolopyrimidines as pi3k lipid kinase inhibitors
JP2010508315A (en) 2006-10-30 2010-03-18 ノバルティス アーゲー Heterocyclic compounds as anti-inflammatory agents
NZ577939A (en) 2007-01-10 2011-03-31 Irm Llc Compounds and compositions as channel activating protease inhibitors
JP5244904B2 (en) 2007-05-07 2013-07-24 ノバルティス アーゲー Organic compounds
NZ585789A (en) 2007-12-10 2012-03-30 Novartis Ag Pyrazine-2-carboxamide derivatives to treat diseases mediated by blockade of the epithelial sodium channel
EP2231642B1 (en) 2008-01-11 2013-10-23 Novartis AG Pyrimidines as kinase inhibitors
KR20110040818A (en) 2008-06-10 2011-04-20 노파르티스 아게 Pyrazine derivatives as epithelial sodium channel blockers
TW201031406A (en) 2009-01-29 2010-09-01 Novartis Ag Substituted benzimidazoles for the treatment of astrocytomas
US8389526B2 (en) 2009-08-07 2013-03-05 Novartis Ag 3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives
MX2012001838A (en) 2009-08-12 2012-02-29 Novartis Ag Heterocyclic hydrazone compounds and their uses to treat cancer and inflammation.
NZ620020A (en) 2009-08-17 2015-06-26 Intellikine Llc Heterocyclic compounds and uses thereof
AU2010284972A1 (en) 2009-08-20 2012-03-08 Novartis Ag Heterocyclic oxime compounds
AU2010310449A1 (en) 2009-10-22 2012-05-03 Vertex Pharmaceuticals Incorporated Compositions for treatment of cystic fibrosis and other chronic diseases
US8247436B2 (en) 2010-03-19 2012-08-21 Novartis Ag Pyridine and pyrazine derivative for the treatment of CF
US8637516B2 (en) 2010-09-09 2014-01-28 Irm Llc Compounds and compositions as TRK inhibitors
WO2012034095A1 (en) 2010-09-09 2012-03-15 Irm Llc Compounds and compositions as trk inhibitors
US8372845B2 (en) 2010-09-17 2013-02-12 Novartis Ag Pyrazine derivatives as enac blockers
US20130324526A1 (en) 2011-02-10 2013-12-05 Novartis Ag [1,2,4] triazolo [4,3-b] pyridazine compounds as inhibitors of the c-met tyrosine kinase
EP2678016B1 (en) 2011-02-23 2016-08-10 Intellikine, LLC Heterocyclic compounds and uses thereof
US9102671B2 (en) 2011-02-25 2015-08-11 Novartis Ag Compounds and compositions as TRK inhibitors
UY34305A (en) 2011-09-01 2013-04-30 Novartis Ag Derivatives bicyclic heterocycles for treating pulmonary arterial hypertension
KR20140077916A (en) 2011-09-15 2014-06-24 노파르티스 아게 6-substituted 3-(quinolin-6-ylthio)-[1,2,4]triazolo[4,3-a]pyradines as tyrosine kinase
EP2755967B1 (en) 2011-09-16 2015-10-21 Novartis AG Heterocyclic compounds for the treatment of cystic fibrosis
WO2013038381A1 (en) 2011-09-16 2013-03-21 Novartis Ag Pyridine/pyrazine amide derivatives
WO2013038373A1 (en) 2011-09-16 2013-03-21 Novartis Ag Pyridine amide derivatives
US9056867B2 (en) 2011-09-16 2015-06-16 Novartis Ag N-substituted heterocyclyl carboxamides
WO2013038378A1 (en) 2011-09-16 2013-03-21 Novartis Ag Pyridine amide derivatives
US9174994B2 (en) 2011-11-23 2015-11-03 Intellikine, Llc Enhanced treatment regimens using mTor inhibitors
US8809340B2 (en) 2012-03-19 2014-08-19 Novartis Ag Crystalline form
WO2013149581A1 (en) 2012-04-03 2013-10-10 Novartis Ag Combination products with tyrosine kinase inhibitors and their use
US9073921B2 (en) 2013-03-01 2015-07-07 Novartis Ag Salt forms of bicyclic heterocyclic derivatives
CN105246482A (en) 2013-03-15 2016-01-13 因特利凯有限责任公司 Combination of kinase inhibitors and uses thereof
WO2015084804A1 (en) 2013-12-03 2015-06-11 Novartis Ag Combination of mdm2 inhibitor and braf inhibitor and their use
US9862711B2 (en) 2014-04-24 2018-01-09 Novartis Ag Pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors
AU2014391605A1 (en) 2014-04-24 2016-10-27 Novartis Ag Amino pyridine derivatives as phosphatidylinositol 3-kinase inhibitors
CA2945212A1 (en) 2014-04-24 2015-10-29 Novartis Ag Amino pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors
AU2015294889B2 (en) 2014-07-31 2018-03-15 Novartis Ag Combination therapy

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1350582A (en) * 1970-07-24 1974-04-18 Ucb Sa Cerivatives of 2-pyrrolidinone
JPS4916872A (en) * 1972-04-21 1974-02-14
JPS5232064B2 (en) * 1972-06-14 1977-08-19
JPS5238227B2 (en) * 1972-06-14 1977-09-28
JPS5751384B2 (en) * 1974-04-25 1982-11-01
US4476311A (en) * 1980-03-12 1984-10-09 The Purdue Frederick Company Analgesic 4-carboxy-pyrrolidin-2-one compound
DE3823299A1 (en) * 1988-07-07 1990-01-11 Schering Ag Substituted phenyl-pyrrolidin-2-one, oxazolidin-2-one and imidazolidin-2-ones, their preparation and use in medicaments

Also Published As

Publication number Publication date
IE921376A1 (en) 1992-11-04
EP0584208A1 (en) 1994-03-02
MX9202090A (en) 1992-11-01
EP0584208A4 (en) 1994-03-23
PT100441A (en) 1993-09-30
CN1067244A (en) 1992-12-23
AU1917092A (en) 1992-12-21
WO1992019594A1 (en) 1992-11-12
JPH06507405A (en) 1994-08-25
ZA9203210B (en) 1993-03-31
CA2102106A1 (en) 1992-11-03

Similar Documents

Publication Publication Date Title
US5143923B1 (en) Benzoisothiazole-and benzisoxazole-3-carboxamides
KR100246065B1 (en) Substituted 3-aminoquinuclidines
DE69216251D1 (en) Substituierte aryl- und heteroaryl-phenyloxazolidinone
KR100218594B1 (en) Bis-benzofuran-2-ones
DE69224906D1 (en) Thermotropes flüssig-kristallines segment-blockcopolymer
DE69222933D1 (en) Cholangiographiekatheter
DE69228822D1 (en) Intubationsvorrichtung
DE69129193D1 (en) Triterpenderivat
DE69228192D1 (en) Wellpappe-palette
DE69213441D1 (en) Analsphinkterprothese
DE69209504D1 (en) Hydroxylfunktionelle polyethersulfonamide als thermoplastisches barriereharz
GB2257579B (en) Pin-header
HU9203143D0 (en) New 9-amino-7-(substituted)-6-demethyl-6-desoxi-tetracyclines
DE69222628D1 (en) Wärmeisolationsmaterial
SG48301A1 (en) New combination
HUH3765A (en) Load
ZA9202154B (en) Transfers
ZA9307780B (en) Substituted benzylaminoquinuclidines
SG52361A1 (en) Novel 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines
ZA9202420B (en) Grf-analogs ii
DE69228486D1 (en) Thrombosefilter
HU9303393D0 (en) Substituted 3-amino-quinuclidines
NZ243454A (en) (indolylmethylene)-2-oxindoles
HU9203552D0 (en) Substituted biphenyl-pyridones
HUT63774A (en) Dust-inhaler